Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Heart and Vessels
Published in: Heart and Vessels 5/2010

01-09-2010 | Original Article

Apelin: a novel marker for the patients with first ST-elevation myocardial infarction

Authors: Agnieszka M. Kuklinska, Bozena Sobkowicz, Robert Sawicki, Wlodzimierz J. Musial, Ewa Waszkiewicz, Swietlana Bolinska, Jolanta Małyszko

Published in: Heart and Vessels | Issue 5/2010

Login to get access
Metadata
Title
Apelin: a novel marker for the patients with first ST-elevation myocardial infarction
Authors
Agnieszka M. Kuklinska
Bozena Sobkowicz
Robert Sawicki
Wlodzimierz J. Musial
Ewa Waszkiewicz
Swietlana Bolinska
Jolanta Małyszko
Publication date
01-09-2010
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 5/2010
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-009-1217-3

Other articles of this Issue 5/2010

Heart and Vessels 5/2010 Go to the issue

Original Article

Short-term effect of levosimendan on free light chain kappa and lambda levels in patients with decompensated chronic heart failure

Original Article

Severe, short-term food restriction improves cardiac function following ischemia/reperfusion in perfused rat hearts

Original Article

Dopamine receptor subtypes in the native human heart

Original Article

Increased C-reactive protein is associated with future development of diabetes mellitus in essential hypertensive patients

Original Article

Two single nucleotide polymorphisms in ALOX15 are associated with risk of coronary artery disease in a Chinese Han population

Case Report

The efficacy of tocilizumab in a patient with pulmonary arterial hypertension associated with Castleman’s disease

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits